Holen Sie sich die Stockscreener-App
34.56
5.60%
-2.05
Handel nachbörslich:
34.00
-0.56
-1.62%
Finanzdaten der Urogen Pharma Ltd-Aktie (URGN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
42.18%
72.46
|
50.96 | 37.84 | 27.48 | 24.21 |
| Cost Of Revenue |
58.78%
6.572
|
4.139 | 3.289 | 3.278 | 3.55 |
| Gross Profit |
40.72%
65.88
|
46.82 | 34.55 | 24.20 | 20.66 |
Selling, General, and Administrative
|
5.92%
48.44
|
51.49 | - | - | - |
| Operating Income/Loss |
100.55%
0.111
|
-20.26 | -19.11 | -27.39 | -41.45 |
| Nonoperating Income/Loss |
7.43%
-0.347
|
-0.323 | -0.005 | -0.197 | -0.378 |
| Income/Loss From Continuing Operations Before Tax |
69.23%
-8.722
|
-28.35 | -26.64 | -34.40 | -48.92 |
| Income Tax Expense/Benefit |
217.96%
5.629
|
-4.772 | -0.275 | -1.054 | 1.015 |
| Net Income/Loss |
39.12%
-14.35
|
-23.57 | -26.36 | -33.35 | -49.94 |
| Basic Average Shares |
0.39%
50.38
|
50.18 | 0.3738 | 48.06 | 47.74 |
| Basic Earnings Per Share |
40.43%
-0.28
|
-0.47 | -0.53 | -0.69 | -1.05 |
1.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):